StockData

Lantheus vs Myriad Genetics

LNTH and MYGN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LNTH and MYGN compare

Lantheus is the larger company, worth 12 times as much as Myriad Genetics ($6.6B against $533M).

Lantheus grew revenue faster over the last twelve months (2.3% versus −3.2% for Myriad Genetics).

Lantheus keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with −14.0% at Myriad Genetics.

Lantheus scores higher on the StockData Score (11 against 6 for Myriad Genetics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLNTHMYGN
Size and price
Market cap$6.6B$533M
Share price$101.72$5.57
Change, 1 year91.5%−12.3%
Change, 5 years265%−79.1%
Beta (5Y)0.41−0.10
Employees1,1932,700
StockData Score
Total score11 (better)6
Valuation score01 (better)
Growth score2 (better)0
Performance score5 (better)3
Health score4 (better)2
Dividend score00
Valuation
P/E24.6×–
P/S4.3×0.7× (better)
P/B5.1×1.8× (better)
EV/EBITDA16.9×–
PEG0.24–
Fair value$91.21–
Margin of safety−11.5%–
Growth
Revenue growth (TTM)2.3% (better)−3.2%
Revenue growth, 5Y average35.3% (better)−0.63%
Net income growth (TTM)1.6%–
EPS growth (TTM)9.5%–
Profitability
Gross margin60.1%68.8% (better)
Operating margin19.4% (better)−12.2%
Net margin17.7% (better)−14.0%
Return on equity22.2% (better)−32.5%
Return on invested capital19.7% (better)−22.8%
Financial health
Debt / equity0.440.40 (better)
Net debt / EBITDA−0.06–
Interest coverage15.3× (better)−6.0×
Current ratio3.06 (better)2.21
Altman Z-score5.52 (better)−0.62
Piotroski F-score55
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions117%94.1%
Held by insiders2.3%7.2%
Insider net buying, 12 months–$655K
Short interest, % of float5.7%9.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.